In this study, we aimed to characterize the pathogenic effect rs9357347 exerted on AD based on the premise that rs9357347, a candidate regulatory variant at the TREM gene cluster, associates with decreased AD risk and increased TREML1 and TREM2 brain gene expression (Carrasquillo et al., 2017). The gene discussed is TREML1; the disease is Alzheimer disease.